Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids
Abstract Here we sought to determine the relationship between STAT3 activity and Galectin‐3 (Gal‐3) and to investigate the cytotoxic effect of PectaSol‐C Modified Citrus Pectin (Pect‐MCP) as a specific competitive inhibitor of Galectin‐3 (Gal‐3) in combination with Paclitaxel (PTX) to kill the ovari...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-08-01
|
| Series: | Cancer Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cam4.2334 |
| _version_ | 1818940831701139456 |
|---|---|
| author | Ghamartaj Hossein Sina Halvaei Yassaman Heidarian Zeinab Dehghani‐Ghobadi Mina Hassani Homa Hosseini Nima Naderi Shahrzad Sheikh Hassani |
| author_facet | Ghamartaj Hossein Sina Halvaei Yassaman Heidarian Zeinab Dehghani‐Ghobadi Mina Hassani Homa Hosseini Nima Naderi Shahrzad Sheikh Hassani |
| author_sort | Ghamartaj Hossein |
| collection | DOAJ |
| description | Abstract Here we sought to determine the relationship between STAT3 activity and Galectin‐3 (Gal‐3) and to investigate the cytotoxic effect of PectaSol‐C Modified Citrus Pectin (Pect‐MCP) as a specific competitive inhibitor of Galectin‐3 (Gal‐3) in combination with Paclitaxel (PTX) to kill the ovarian cancer cell SKOV‐3 multicellular tumor spheroid (MCTS). To this order, SKOV‐3 cells in 2D and 3D cultures were treated with exogenous Gal‐3 for the assessment of STAT3 activity. Two‐way ANOVA main effect and IC50 of each drug Paclitaxel (PTX) and Pect‐MCP or in combination were obtained from MTT assay results. The phosphorylated STAT3 levels, migration, invasion, integrin mRNA and p‐AKTser473 levels were assessed in the absence or presence of each drug alone or in combination. Gal‐3 expression levels were assessed in human serous ovarian cancer (SOC) specimens and its correlation with different integrin mRNA levels was further assessed. Our results showed that Gal‐3 expression level was significantly increased in MCTS compared to monolayer SKOV‐3 cells which triggered STAT3 phosphorylation. Moreover, Pect‐MCP synergized with PTX to kill SKOV3 MCTS through abrogation of STAT3 activity and reduced expression of its downstream target HIF‐1α, reduced integrin mRNA levels, and subsequently decreased AKT activity. There were higher expression levels of Gal‐3 in human high‐grade SOC specimens compared to the normal ovary and borderline SOC which positively and significantly correlated with α5, β2 and β6 integrin mRNA levels. Together, these results revealed for the first time that Pect‐MCP could be considered as a potential drug to enhance the PTX effect on ovarian cancer cells MCTS through inhibition of STAT3 activity. |
| first_indexed | 2024-12-20T06:45:54Z |
| format | Article |
| id | doaj.art-4d55125611f3460690c4fca8917d87fe |
| institution | Directory Open Access Journal |
| issn | 2045-7634 |
| language | English |
| last_indexed | 2024-12-20T06:45:54Z |
| publishDate | 2019-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Medicine |
| spelling | doaj.art-4d55125611f3460690c4fca8917d87fe2022-12-21T19:49:43ZengWileyCancer Medicine2045-76342019-08-01894315432910.1002/cam4.2334Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroidsGhamartaj Hossein0Sina Halvaei1Yassaman Heidarian2Zeinab Dehghani‐Ghobadi3Mina Hassani4Homa Hosseini5Nima Naderi6Shahrzad Sheikh Hassani7Department of Animal Biology, Developmental Biology Laboratory, College of Science University of Tehran Tehran IranDepartment of Animal Biology, Developmental Biology Laboratory, College of Science University of Tehran Tehran IranDepartment of Animal Biology, Developmental Biology Laboratory, College of Science University of Tehran Tehran IranDepartment of Animal Biology, Developmental Biology Laboratory, College of Science University of Tehran Tehran IranDepartment of Animal Biology, Developmental Biology Laboratory, College of Science University of Tehran Tehran IranDepartment of Animal Biology, Developmental Biology Laboratory, College of Science University of Tehran Tehran IranNeuroscience Research Center Shahid Beheshti University (Medical Sciences) Tehran IranDepartment of Gynecology Oncology Valiasr Imam Khomeini Hospital, Tehran University of Medical Science Tehran IranAbstract Here we sought to determine the relationship between STAT3 activity and Galectin‐3 (Gal‐3) and to investigate the cytotoxic effect of PectaSol‐C Modified Citrus Pectin (Pect‐MCP) as a specific competitive inhibitor of Galectin‐3 (Gal‐3) in combination with Paclitaxel (PTX) to kill the ovarian cancer cell SKOV‐3 multicellular tumor spheroid (MCTS). To this order, SKOV‐3 cells in 2D and 3D cultures were treated with exogenous Gal‐3 for the assessment of STAT3 activity. Two‐way ANOVA main effect and IC50 of each drug Paclitaxel (PTX) and Pect‐MCP or in combination were obtained from MTT assay results. The phosphorylated STAT3 levels, migration, invasion, integrin mRNA and p‐AKTser473 levels were assessed in the absence or presence of each drug alone or in combination. Gal‐3 expression levels were assessed in human serous ovarian cancer (SOC) specimens and its correlation with different integrin mRNA levels was further assessed. Our results showed that Gal‐3 expression level was significantly increased in MCTS compared to monolayer SKOV‐3 cells which triggered STAT3 phosphorylation. Moreover, Pect‐MCP synergized with PTX to kill SKOV3 MCTS through abrogation of STAT3 activity and reduced expression of its downstream target HIF‐1α, reduced integrin mRNA levels, and subsequently decreased AKT activity. There were higher expression levels of Gal‐3 in human high‐grade SOC specimens compared to the normal ovary and borderline SOC which positively and significantly correlated with α5, β2 and β6 integrin mRNA levels. Together, these results revealed for the first time that Pect‐MCP could be considered as a potential drug to enhance the PTX effect on ovarian cancer cells MCTS through inhibition of STAT3 activity.https://doi.org/10.1002/cam4.2334Galectin‐3integrininvasionmigrationovarian cancerSTAT3 |
| spellingShingle | Ghamartaj Hossein Sina Halvaei Yassaman Heidarian Zeinab Dehghani‐Ghobadi Mina Hassani Homa Hosseini Nima Naderi Shahrzad Sheikh Hassani Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids Cancer Medicine Galectin‐3 integrin invasion migration ovarian cancer STAT3 |
| title | Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids |
| title_full | Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids |
| title_fullStr | Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids |
| title_full_unstemmed | Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids |
| title_short | Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids |
| title_sort | pectasol c modified citrus pectin targets galectin 3 induced stat3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids |
| topic | Galectin‐3 integrin invasion migration ovarian cancer STAT3 |
| url | https://doi.org/10.1002/cam4.2334 |
| work_keys_str_mv | AT ghamartajhossein pectasolcmodifiedcitruspectintargetsgalectin3inducedstat3activationandsynergizepaclitaxelcytotoxiceffectonovariancancerspheroids AT sinahalvaei pectasolcmodifiedcitruspectintargetsgalectin3inducedstat3activationandsynergizepaclitaxelcytotoxiceffectonovariancancerspheroids AT yassamanheidarian pectasolcmodifiedcitruspectintargetsgalectin3inducedstat3activationandsynergizepaclitaxelcytotoxiceffectonovariancancerspheroids AT zeinabdehghanighobadi pectasolcmodifiedcitruspectintargetsgalectin3inducedstat3activationandsynergizepaclitaxelcytotoxiceffectonovariancancerspheroids AT minahassani pectasolcmodifiedcitruspectintargetsgalectin3inducedstat3activationandsynergizepaclitaxelcytotoxiceffectonovariancancerspheroids AT homahosseini pectasolcmodifiedcitruspectintargetsgalectin3inducedstat3activationandsynergizepaclitaxelcytotoxiceffectonovariancancerspheroids AT nimanaderi pectasolcmodifiedcitruspectintargetsgalectin3inducedstat3activationandsynergizepaclitaxelcytotoxiceffectonovariancancerspheroids AT shahrzadsheikhhassani pectasolcmodifiedcitruspectintargetsgalectin3inducedstat3activationandsynergizepaclitaxelcytotoxiceffectonovariancancerspheroids |